Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)
Abstract Introduction Pneumonia is the most common cause of mortality from infectious diseases, the second leading cause of nosocomial infection, and the leading cause of mortality among hospitalized adults. To improve clinical management, metabolomics has been increasingly applied to find specific...
Main Authors: | Mohammad M. Banoei, Hans J. Vogel, Aalim M. Weljie, Sachin Yende, Derek C. Angus, Brent W. Winston |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-03147-3 |
Similar Items
-
Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia
by: Mohammad M. Banoei, et al.
Published: (2017-04-01) -
Mortality predictors in patients with severe community-acquired pneumonia requiring ICU admission
by: Ali O. Abdel Aziz, et al.
Published: (2016-06-01) -
COVID-19 mortality and ICU admission: the Italian experience
by: Paolo Immovilli, et al.
Published: (2020-05-01) -
Synthetic mRNA capping
by: Fabian Muttach, et al.
Published: (2017-12-01) -
On improving assessment of in-hospital mortality and ICU admission in community-acquired pneumonia patients using the eCURB
by: Lamia Shaaban, et al.
Published: (2012-07-01)